Literature DB >> 23604513

Changes in fundus autofluorescence in polypoidal choroidal vasculopathy during 3 years of follow-up.

Mihoko Suzuki1, Fumi Gomi, Miki Sawa, Chikako Ueno, Kohji Nishida.   

Abstract

PURPOSE: To investigate changes in fundus autofluorescence (FAF) during 3 years of follow-up in patients with polypoidal choroidal vasculopathy (PCV).
DESIGN: Retrospective study.
METHODS: We retrospectively reviewed the charts of 48 eyes of 47 patients (35 men, 12 women; mean age, 69.9 ± 7.1 years) with treatment-naïve PCV for whom FAF and indocyanine green angiography (ICGA) images were available at baseline and at 3 years ± 3 months follow-up examination. The main outcome measures were the FAF changes during 3 years of follow-up, and the correlation between them and polypoidal lesions and branching vascular networks on ICGA.
RESULTS: The FAF of the polypoidal lesions showed three patterns at baseline and changes during 3 years of follow-up: confluent hypoautofluorescence surrounded by a hyperautofluorescent ring (86.1% → 51.4%), confluent hypoautofluorescence without a ring (8.3% → 43.0%), and no marked changes (5.6% → 5.6%). The FAF in 96.2% of resolved polypoidal lesions persisted on images with abnormal FAF during the 3 years of follow-up. The granular hypoautofluorescence at the branching vascular networks at baseline became partially confluent hypoautofluorescence in 41 eyes (85.4%). The mean area with confluent hypoautofluorescence that corresponded to the branching vascular network lesions increased significantly (P < 0.001) from 1.75 mm(2) to 5.10 mm(2) after 3 years of follow-up.
CONCLUSION: The FAF changes in PCV during the 3 years of follow-up can indicate that FAF imaging is a useful and clinically beneficial tool for noninvasively evaluating the PCV lesions and disorders of the upper retinal pigment epithelium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23604513     DOI: 10.1007/s00417-013-2336-1

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  20 in total

1.  Fundus autofluorescence and development of geographic atrophy in age-related macular degeneration.

Authors:  F G Holz; C Bellman; S Staudt; F Schütt; H E Völcker
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.

Authors:  Ramzi G Sayegh; Christian Simader; Ulrike Scheschy; Alessio Montuoro; Christopher Kiss; Stefan Sacu; David P Kreil; Christian Prünte; Ursula Schmidt-Erfurth
Journal:  Ophthalmology       Date:  2011-04-15       Impact factor: 12.079

3.  Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy.

Authors:  Taku Sato; Shoji Kishi; Goro Watanabe; Hidetaka Matsumoto; Ryo Mukai
Journal:  Retina       Date:  2007-06       Impact factor: 4.256

4.  Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope.

Authors:  A von Rückmann; F W Fitzke; A C Bird
Journal:  Invest Ophthalmol Vis Sci       Date:  1997-02       Impact factor: 4.799

5.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

6.  Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.

Authors:  Masaaki Saito; Tomohiro Iida; Mariko Kano
Journal:  Retina       Date:  2011-09       Impact factor: 4.256

7.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

8.  Optical coherence tomographic findings of idiopathic polypoidal choroidal vasculopathy.

Authors:  T Otsuji; K Takahashi; I Fukushima; M Uyama
Journal:  Ophthalmic Surg Lasers       Date:  2000 May-Jun

9.  Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy.

Authors:  R F Spaide; L A Yannuzzi; J S Slakter; J Sorenson; D A Orlach
Journal:  Retina       Date:  1995       Impact factor: 4.256

10.  Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography.

Authors:  Yumiko Ojima; Masanori Hangai; Atsushi Sakamoto; Akitaka Tsujikawa; Atsushi Otani; Hiroshi Tamura; Nagahisa Yoshimura
Journal:  Retina       Date:  2009-01       Impact factor: 4.256

View more
  4 in total

1.  VISUALIZING RETINAL PIGMENT EPITHELIUM PHENOTYPES IN THE TRANSITION TO ATROPHY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.

Authors:  Emma C Zanzottera; Thomas Ach; Carrie Huisingh; Jeffrey D Messinger; K Bailey Freund; Christine A Curcio
Journal:  Retina       Date:  2016-12       Impact factor: 4.256

2.  Characteristic appearances of fundus autofluorescence in treatment-naive and active polypoidal choroidal vasculopathy: a retrospective study of 170 patients.

Authors:  Xinyu Zhao; Song Xia; Youxin Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-14       Impact factor: 3.117

3.  Characteristics of Fundus Autofluorescence in Active Polypoidal Choroidal Vasculopathy.

Authors:  Zafer Öztaş; Jale Menteş; Serhad Nalçacı; Mine Barış
Journal:  Turk J Ophthalmol       Date:  2016-08-15

4.  Noninvasive multimodal imaging in diagnosing polypoidal choroidal vasculopathy.

Authors:  Jingyuan Yang; Mingzhen Yuan; Erqian Wang; Song Xia; Youxin Chen
Journal:  BMC Ophthalmol       Date:  2019-11-16       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.